Methodological approaches and insights on protein aggregation in biological systems

ABSTRACT Introduction: The proper folding of native proteins is critical and dynamic, but inherently unstable. Therefore, proteins eventually end up adopting misfolded conformations which compromise their function and may even trigger aggregation. Risk factors for neurodegenerative, metabolic and heart diseases compromise cellular protein quality-control systems, promoting protein aggregation. Multiple protein post-translational modifications dynamically regulate protein aggregation and disaggregation in a very complex, intricate and delicate balance. Areas covered: Herein, we overview the more promising techniques and approaches for the elucidation of the biological implications of protein aggregation. The particular insights provided by different techniques were discriminated and several examples of post-translational modifications together with their targets were pooled and critically discussed, representing promising future therapeutic targets. Expert commentary: In the years to come, differences between physiological and pathological protein aggregation will certainly become easier to determine. Techniques such as hydrogen/deuterium exchange, circular dichroism spectroscopy and novel mass spectrometry-based approaches are being optimized and are expected to introduce inhibitors of protein aggregation into the clinic. However, protein aggregation is not an isolated phenomenon, but rather influenced by multiple cellular components which complete knowledge is still far.

[1]  M. Mann,et al.  Widespread Proteome Remodeling and Aggregation in Aging C. elegans , 2017, Cell.

[2]  E. O’Brien,et al.  Extracellular Release and Signaling by Heat Shock Protein 27: Role in Modifying Vascular Inflammation , 2016, Front. Immunol..

[3]  K. Otsu,et al.  Autophagy during cardiac remodeling. , 2016, Journal of molecular and cellular cardiology.

[4]  J. Mehta,et al.  Age- and Hypertension-Associated Protein Aggregates in Mouse Heart Have Similar Proteomic Profiles , 2016, Hypertension.

[5]  R. Morimoto,et al.  The biology of proteostasis in aging and disease. , 2015, Annual review of biochemistry.

[6]  Xianlin Sun,et al.  Doxycycline ameliorates aggregation of collagen and atrial natriuretic peptide in murine post-infarction heart. , 2015, European journal of pharmacology.

[7]  Rafael Zambrano,et al.  AGGRESCAN3D (A3D): server for prediction of aggregation properties of protein structures , 2015, Nucleic Acids Res..

[8]  Dmitri I. Svergun,et al.  The architecture of amyloid-like peptide fibrils revealed by X-ray scattering, diffraction and electron microscopy , 2015, Acta crystallographica. Section D, Biological crystallography.

[9]  Jie Sui,et al.  Cullin Family Proteins and Tumorigenesis: Genetic Association and Molecular Mechanisms , 2015, Journal of Cancer.

[10]  T. McKinsey,et al.  Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy , 2014, Proceedings of the National Academy of Sciences.

[11]  I. Kaltashov,et al.  Characterization of small protein aggregates and oligomers using size exclusion chromatography with online detection by native electrospray ionization mass spectrometry. , 2014, Analytical chemistry.

[12]  M. Sharon,et al.  Regulating the 20S Proteasome Ubiquitin-Independent Degradation Pathway , 2014, Biomolecules.

[13]  G. Agnetti,et al.  Protein post‐translational modifications and misfolding: New concepts in heart failure , 2014, Proteomics. Clinical applications.

[14]  J. Hoseki,et al.  Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition , 2014, Scientific Reports.

[15]  M. Heneka,et al.  Truncated and modified amyloid-beta species , 2014, Alzheimer's Research & Therapy.

[16]  M. Michalak,et al.  The many functions of the endoplasmic reticulum chaperones and folding enzymes , 2014, IUBMB life.

[17]  D. Kass,et al.  Desmin modifications associate with amyloid-like oligomers deposition in heart failure. , 2014, Cardiovascular research.

[18]  A. Rosenberg,et al.  New FDA Draft Guidance on Immunogenicity , 2014, The AAPS Journal.

[19]  A. Simm,et al.  Role of advanced glycation end products in cellular signaling , 2014, Redox biology.

[20]  Chadwick M. Hales,et al.  Pharmacologic Inhibition of ROCK2 Suppresses Amyloid-β Production in an Alzheimer's Disease Mouse Model , 2013, The Journal of Neuroscience.

[21]  B. Raman,et al.  The Extracellular Chaperone Haptoglobin Prevents Serum Fatty Acid-promoted Amyloid Fibril Formation of β2-Microglobulin, Resistance to Lysosomal Degradation, and Cytotoxicity , 2013, The Journal of Biological Chemistry.

[22]  Charles D. Schwieters,et al.  Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue , 2013, Cell.

[23]  Casey Cook,et al.  Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance , 2013, Human molecular genetics.

[24]  Michael A Weiss,et al.  Diabetes mellitus due to the toxic misfolding of proinsulin variants , 2013, FEBS letters.

[25]  L. Xue,et al.  Evaluation of Pre-existing Antibody Presence as a Risk Factor for Posttreatment Anti-drug Antibody Induction: Analysis of Human Clinical Study Data for Multiple Biotherapeutics , 2013, The AAPS Journal.

[26]  S. Ausar,et al.  Forced degradation studies: an essential tool for the formulation development of vaccines , 2013 .

[27]  V. Lee,et al.  The microtubule-associated tau protein has intrinsic acetyltransferase activity , 2013, Nature Structural &Molecular Biology.

[28]  Cam Patterson,et al.  Proteotoxicity and cardiac dysfunction--Alzheimer's disease of the heart? , 2013, The New England journal of medicine.

[29]  Xuejun Wang,et al.  Posttranslational modification and quality control. , 2013, Circulation research.

[30]  C. MacPhee,et al.  Mass spectrometry methods for intrinsically disordered proteins. , 2013, The Analyst.

[31]  V. Andrisano,et al.  Disclosure of a fundamental clue for the elucidation of the myricetin mechanism of action as amyloid aggregation inhibitor by mass spectrometry , 2012, Electrophoresis.

[32]  S. Finkbeiner,et al.  Protein aggregates in Huntington's disease , 2012, Experimental Neurology.

[33]  Nobel C. Zong,et al.  Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics. , 2012, American journal of physiology. Heart and circulatory physiology.

[34]  A. Levey,et al.  Coaggregation of RNA-Binding Proteins in a Model of TDP-43 Proteinopathy with Selective RGG Motif Methylation and a Role for RRM1 Ubiquitination , 2012, PloS one.

[35]  K. Chung,et al.  Neddylation positively regulates the ubiquitin E3 ligase activity of parkin , 2012, Journal of neuroscience research.

[36]  J. Trojanowski,et al.  Redox signalling directly regulates TDP‐43 via cysteine oxidation and disulphide cross‐linking , 2012, The EMBO journal.

[37]  Bradford W Gibson,et al.  Proteomic analysis of age-dependent changes in protein solubility identifies genes that modulate lifespan , 2012, Aging cell.

[38]  I. Kaltashov,et al.  Evaluation of electrospray ionization mass spectrometry as a tool for characterization of small soluble protein aggregates. , 2012, Analytical chemistry.

[39]  S. Joshi,et al.  Investigation of protein conformational stability employing a multimodal spectrometer. , 2011, Analytical chemistry.

[40]  M. Ohno,et al.  Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis , 2011, Autophagy.

[41]  C. Behl BAG3 and friends: Co-chaperones in selective autophagy during aging and disease , 2011, Autophagy.

[42]  Thomas Hartmann,et al.  The cullin protein family , 2011, Genome Biology.

[43]  U. Wolfrum,et al.  BAG3 mediates chaperone‐based aggresome‐targeting and selective autophagy of misfolded proteins , 2011, EMBO reports.

[44]  Jinbao Liu,et al.  Perturbation of Cullin Deneddylation via Conditional Csn8 Ablation Impairs the Ubiquitin–Proteasome System and Causes Cardiomyocyte Necrosis and Dilated Cardiomyopathy in Mice , 2011, Circulation research.

[45]  A. Boyle,et al.  The aging heart and post-infarction left ventricular remodeling. , 2011, Journal of the American College of Cardiology.

[46]  I. Kaltashov,et al.  Impact of oxidation on protein therapeutics: Conformational dynamics of intact and oxidized acid‐β‐glucocerebrosidase at near‐physiological pH , 2010, Protein science : a publication of the Protein Society.

[47]  N. Perrimon,et al.  FOXO/4E-BP Signaling in Drosophila Muscles Regulates Organism-wide Proteostasis during Aging , 2010, Cell.

[48]  Bernd Bukau,et al.  Cellular strategies for controlling protein aggregation , 2010, Nature Reviews Molecular Cell Biology.

[49]  P. Ping,et al.  Differential Regulation of Proteasome Function in Isoproterenol-Induced Cardiac Hypertrophy , 2010, Circulation research.

[50]  P. Palumaa,et al.  Label-free high-throughput screening assay for inhibitors of Alzheimer's amyloid-β peptide aggregation based on MALDI MS. , 2010, Analytical chemistry.

[51]  Alma L. Burlingame,et al.  Widespread Protein Aggregation as an Inherent Part of Aging in C. elegans , 2010, PLoS biology.

[52]  M. Sukumar,et al.  Quantification and characterization of subvisible proteinaceous particles in opalescent mAb formulations using micro-flow imaging. , 2010, Journal of pharmaceutical sciences.

[53]  C. Holmberg,et al.  A photoconvertible reporter of the ubiquitin-proteasome system in vivo , 2010, Nature Methods.

[54]  F. Pagani,et al.  Ubiquitin Proteasome Dysfunction in Human Hypertrophic and Dilated Cardiomyopathies , 2010, Circulation.

[55]  M. Sheng,et al.  Autophosphorylated CaMKIIα Acts as a Scaffold to Recruit Proteasomes to Dendritic Spines , 2010, Cell.

[56]  C. Behl,et al.  HSF1-Controlled and Age-Associated Chaperone Capacity in Neurons and Muscle Cells of C. elegans , 2010, PloS one.

[57]  D. Klionsky,et al.  Regulation mechanisms and signaling pathways of autophagy. , 2009, Annual review of genetics.

[58]  Subhash D. Katewa,et al.  4E-BP Extends Lifespan upon Dietary Restriction by Enhancing Mitochondrial Activity in Drosophila , 2009, Cell.

[59]  Chi-Ting Huang,et al.  Quantitation of protein particles in parenteral solutions using micro-flow imaging. , 2009, Journal of pharmaceutical sciences.

[60]  Elizabeth A Miller,et al.  Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging , 2009, Proceedings of the National Academy of Sciences.

[61]  Xin Lin,et al.  The E3 Ligase TRAF6 Regulates Akt Ubiquitination and Activation , 2009, Science.

[62]  C. Maas,et al.  Physiological responses to protein aggregates: Fibrinolysis, coagulation and inflammation (new roles for old factors) , 2009, FEBS letters.

[63]  W. Engel,et al.  Inclusion Body Myositis: A Degenerative Muscle Disease Associated with Intra‐Muscle Fiber Multi‐Protein Aggregates, Proteasome Inhibition, Endoplasmic Reticulum Stress and Decreased Lysosomal Degradation , 2009, Brain pathology.

[64]  J. Philo,et al.  A critical review of methods for size characterization of non-particulate protein aggregates. , 2009, Current pharmaceutical biotechnology.

[65]  Christopher M. Dobson,et al.  Experimental characterization of disordered and ordered aggregates populated during the process of amyloid fibril formation , 2009, Proceedings of the National Academy of Sciences.

[66]  K. Davies,et al.  Mitochondrial Lon protease is a human stress protein. , 2009, Free radical biology & medicine.

[67]  Shoji Takada,et al.  Bimodal protein solubility distribution revealed by an aggregation analysis of the entire ensemble of Escherichia coli proteins , 2009, Proceedings of the National Academy of Sciences.

[68]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[69]  N. Durany,et al.  Oxidative stress in Alzheimer disease , 2009, Cell adhesion & migration.

[70]  Masayuki Miura,et al.  Genetic Evidence Linking Age-Dependent Attenuation of the 26S Proteasome with the Aging Process , 2008, Molecular and Cellular Biology.

[71]  F. Regnier,et al.  Protein:protein aggregation induced by protein oxidation. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[72]  C. Maas,et al.  Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. , 2008, The Journal of clinical investigation.

[73]  Tommer Ravid,et al.  Diversity of degradation signals in the ubiquitin–proteasome system , 2008, Nature Reviews Molecular Cell Biology.

[74]  Daniel Kaganovich,et al.  Misfolded proteins partition between two distinct quality control compartments , 2008, Nature.

[75]  Liming Zhao,et al.  Simultaneous monitoring of peptide aggregate distributions, structure, and kinetics using amide hydrogen exchange: Application to Aβ(1‐40) fibrillogenesis , 2008, Biotechnology and bioengineering.

[76]  Janet L. Johnstone,et al.  Intracellular Protein Aggregation Is a Proximal Trigger of Cardiomyocyte Autophagy , 2008, Circulation.

[77]  J. Landry,et al.  HspB8 and Bag3: A new chaperone complex targeting misfolded proteins to macroautophagy , 2008, Autophagy.

[78]  C. Maas,et al.  Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[79]  A. Cavalli,et al.  Insight Into the Kinetic of Amyloid β (1–42) Peptide Self‐Aggregation: Elucidation of Inhibitors’ Mechanism of Action , 2007, Chembiochem : a European journal of chemical biology.

[80]  A. Ariza,et al.  Protein Aggregation Mechanisms in Synucleinopathies: Commonalities and Differences , 2007, Journal of neuropathology and experimental neurology.

[81]  G. Farr,et al.  Two families of chaperonin: physiology and mechanism. , 2007, Annual review of cell and developmental biology.

[82]  R. Palmiter,et al.  Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6 , 2007, The Journal of cell biology.

[83]  T. Yao,et al.  HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. , 2007, Genes & development.

[84]  L A M van der Wielen,et al.  Surfactant-aided size-exclusion chromatography for the purification of immunoglobulin G. , 2007, Journal of chromatography. A.

[85]  L. Papa,et al.  Reactive oxygen species induced by proteasome inhibition in neuronal cells mediate mitochondrial dysfunction and a caspase-independent cell death , 2007, Apoptosis.

[86]  R. Kayed,et al.  Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct* , 2007, Journal of Biological Chemistry.

[87]  W. Surewicz,et al.  β-Sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange , 2007, Proceedings of the National Academy of Sciences.

[88]  N. Rosen,et al.  An acetylation site in the middle domain of Hsp90 regulates chaperone function. , 2007, Molecular cell.

[89]  I. Rubinstein,et al.  PEGylated phospholipid nanomicelles interact with β-amyloid(1–42) and mitigate its β-sheet formation, aggregation and neurotoxicity in vitro , 2006, Peptides.

[90]  Brian J Bacskai,et al.  Plaque-Derived Oxidative Stress Mediates Distorted Neurite Trajectories in the Alzheimer Mouse Model , 2006, Journal of neuropathology and experimental neurology.

[91]  D. Rubinsztein,et al.  The roles of intracellular protein-degradation pathways in neurodegeneration , 2006, Nature.

[92]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[93]  D I Svergun,et al.  The impact of protein characterization in structural proteomics , 2006, Acta crystallographica. Section D, Biological crystallography.

[94]  J. Scholz,et al.  Interaction of the amyloid precursor like protein 1 with the alpha2A-adrenergic receptor increases agonist-mediated inhibition of adenylate cyclase. , 2006, Cellular signalling.

[95]  Ehud Cohen,et al.  Opposing Activities Protect Against Age-Onset Proteotoxicity , 2006, Science.

[96]  A. Rosenberg,et al.  Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.

[97]  L. Chao,et al.  The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction , 2006, Biological chemistry.

[98]  J. Busciglio,et al.  Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons , 2006, The Journal of Neuroscience.

[99]  J. Weissman,et al.  Molecular Chaperones and Protein Quality Control , 2006, Cell.

[100]  A. Bonvin,et al.  The α‐to‐β Conformational Transition of Alzheimer's Aβ‐(1–42) Peptide in Aqueous Media is Reversible: A Step by Step Conformational Analysis Suggests the Location of β Conformation Seeding , 2006 .

[101]  Bin Chen,et al.  The HSP90 family of genes in the human genome: insights into their divergence and evolution. , 2005, Genomics.

[102]  Sheena E Radford,et al.  The Yin and Yang of protein folding , 2005, The FEBS journal.

[103]  R. Abraham,et al.  Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. , 2005, Molecular cell.

[104]  T. Sommer,et al.  ERAD: the long road to destruction , 2005, Nature Cell Biology.

[105]  S. Ferré,et al.  Amazing stability of the arginine-phosphate electrostatic interaction. , 2005, Journal of proteome research.

[106]  T. Dawson,et al.  Response to Comment on "S-Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function" , 2005, Science.

[107]  J. Brodsky,et al.  Use of yeast as a model system to investigate protein conformational diseases , 2005, Molecular biotechnology.

[108]  Minoru Yoshida,et al.  HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. , 2005, Molecular cell.

[109]  Thomas Nyström,et al.  Role of oxidative carbonylation in protein quality control and senescence , 2005, The EMBO journal.

[110]  C. R. Middaugh,et al.  Silicone oil induced aggregation of proteins. , 2005, Journal of pharmaceutical sciences.

[111]  M. Manning,et al.  Heterogeneous nucleation-controlled particulate formation of recombinant human platelet-activating factor acetylhydrolase in pharmaceutical formulation. , 2005, Journal of pharmaceutical sciences.

[112]  J. Hoh,et al.  Amyloid-β Protofibrils Differ from Amyloid-β Aggregates Induced in Dilute Hexafluoroisopropanol in Stability and Morphology* , 2005, Journal of Biological Chemistry.

[113]  S. Yokoyama,et al.  Phosphorylation analysis of 90 kDa heat shock protein within the cytosolic arylhydrocarbon receptor complex. , 2004, Biochemistry.

[114]  V. Uversky,et al.  The effect of macromolecular crowding on protein aggregation and amyloid fibril formation , 2004, Journal of molecular recognition : JMR.

[115]  I. Teraoka Calibration of retention volume in size exclusion chromatography by hydrodynamic radius , 2004 .

[116]  Huub Schellekens,et al.  Structure-Immunogenicity Relationships of Therapeutic Proteins , 2004, Pharmaceutical Research.

[117]  C. Dobson Protein folding and misfolding , 2003, Nature.

[118]  E. Forest,et al.  Use of different proteases working in acidic conditions to improve sequence coverage and resolution in hydrogen/deuterium exchange of large proteins. , 2003, Rapid communications in mass spectrometry : RCM.

[119]  D. Geschwind Tau Phosphorylation, Tangles, and Neurodegeneration The Chicken or the Egg? , 2003, Neuron.

[120]  V. Andrisano,et al.  beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. , 2003, Biochemical pharmacology.

[121]  J. Trojanowski,et al.  Phosphorylated α-Synuclein Is Ubiquitinated in α-Synucleinopathy Lesions* , 2002, The Journal of Biological Chemistry.

[122]  D. Teplow,et al.  Kinetic Studies of Amyloid β-Protein Fibril Assembly , 2002, The Journal of Biological Chemistry.

[123]  Richard I. Morimoto,et al.  The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[124]  E. Masliah,et al.  α-Synuclein is phosphorylated in synucleinopathy lesions , 2002, Nature Cell Biology.

[125]  R. Lal,et al.  Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[126]  B. Friguet,et al.  Oxidative Modification and Inactivation of the Proteasome during Coronary Occlusion/Reperfusion* , 2001, The Journal of Biological Chemistry.

[127]  N. C. Price,et al.  The use of circular dichroism in the investigation of protein structure and function. , 2000, Current protein & peptide science.

[128]  P. Fraser,et al.  Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid. , 2000, The Journal of biological chemistry.

[129]  Hans-Georg Rammensee,et al.  gp96—The immune system's Swiss army knife , 2000, Nature Immunology.

[130]  J. Schenck Safety of Strong, Static Magnetic Fields , 2000, Journal of magnetic resonance imaging : JMRI.

[131]  D. Walsh,et al.  An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments , 2000, Neurobiology of Aging.

[132]  E. Stadtman,et al.  Protein Oxidation , 2000, Annals of the New York Academy of Sciences.

[133]  E. Shacter QUANTIFICATION AND SIGNIFICANCE OF PROTEIN OXIDATION IN BIOLOGICAL SAMPLES* , 2000, Drug metabolism reviews.

[134]  R. Kopito,et al.  Aggresomes: A Cellular Response to Misfolded Proteins , 1998, The Journal of cell biology.

[135]  P. Lansbury,et al.  Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. , 1997, Chemistry & biology.

[136]  C. Yu,et al.  Acetonitrile-induced conformational transitions in poly-L-lysine. , 1997, International journal of biological macromolecules.

[137]  J. Riordan,et al.  Multiple proteolytic systems, including the proteasome, contribute to CFTR processing , 1995, Cell.

[138]  B. Friguet,et al.  Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. , 1994, Archives of biochemistry and biophysics.

[139]  Zhongqi Zhang,et al.  Determination of amide hydrogen exchange by mass spectrometry: A new tool for protein structure elucidation , 1993, Protein science : a publication of the Protein Society.

[140]  C. Masters,et al.  Mechanisms of Amyloid Deposition in Alzheimer's Disease a , 1991, Annals of the New York Academy of Sciences.

[141]  Sílvia Bronsoms,et al.  Applications of mass spectrometry to the study of protein aggregation. , 2015, Methods in molecular biology.

[142]  F. Fieschi,et al.  Investigating alternative acidic proteases for H/D exchange coupled to mass spectrometry: Plasmepsin 2 but not plasmepsin 4 is active under quenching conditions , 2010, Journal of the American Society for Mass Spectrometry.

[143]  A. Giuliani,et al.  Bmc Structural Biology a Knowledge-based Structure-discriminating Function That Requires Only Main-chain Atom Coordinates , 2008 .

[144]  Neil E. Jacobsen,et al.  NMR spectroscopy explained : simplified theory, applications and examples for organic chemistry and structural biology , 2007 .

[145]  A. Bonvin,et al.  The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding. , 2006, Chembiochem : a European journal of chemical biology.

[146]  C. Soto,et al.  Amyloid inhibitors and beta-sheet breakers. , 2005, Sub-cellular biochemistry.

[147]  J. Hoh,et al.  Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology. , 2005, The Journal of biological chemistry.

[148]  C. Soto,et al.  Beta-sheet breakers for Alzheimer's disease therapy. , 2004, Current drug targets.

[149]  G. Münch,et al.  Advanced glycation endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5Y. , 2003, Journal of Alzheimer's disease : JAD.

[150]  D. Teplow,et al.  Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. , 2002, The Journal of biological chemistry.

[151]  E. Voest,et al.  Tissue-type plasminogen activator is a multiligand cross-beta structure receptor. , 2002, Current biology : CB.

[152]  J. Trojanowski,et al.  Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. , 2002, The Journal of biological chemistry.